Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Going fishing in the protein pond using histones as a bait – how do cells decide how to repair their DNA?

26.02.2019

When DNA in the cell nucleus gets damaged, our cells can resort to a variety of repair mechanisms. A recent study published in 'Nature Cell Biology', to which scientists from Helmholtz Zentrum München made major contributions, elucidates the molecular basis by which a cell makes the choice between these repair mechanisms. The trick the scientists used: they developed a molecular bait to literally fish out the relevant proteins from the cell nucleus. According to the authors, this study opens up new possibilities for cancer therapies in the future.

When DNA in the cell nucleus gets damaged, our cells can resort to a variety of repair mechanisms. A recent study published in 'Nature Cell Biology', to which scientists from Helmholtz Zentrum München made major contributions, elucidates the molecular basis by which a cell makes the choice between these repair mechanisms.


The choice between the repair mechanisms is made at the molecule BARD1 © Helmholtz Zentrum München

The trick the scientists used: they developed a molecular bait to literally fish out the relevant proteins from the cell nucleus. According to the authors, this study opens up new possibilities for cancer therapies in the future.

The sequence of base pairs in the DNA contains the genetic information of all living things. Not all genes, however, are active at the same time – this also depends on other factors that are happening around the DNA. Histones play a major role in this.

"Histones are proteins around which our DNA is wrapped and which thus serve to package the genetic material," says corresponding author Dr. Till Bartke, deputy director of the Institute of Functional Epigenetics (IFE) at Helmholtz Zentrum München.

"Depending on how the histones are chemically modified, they can have different effects on the DNA and control gene activity”. The primary aim of Bartke and the IFE is to find out how this so-called 'histone code' works.

To achieve this, the researchers reconstruct known chemical histone modifications in a test tube and investigate which proteins selectively bind to them in an extract made from the nuclei of cells. "Put simply, we build a molecular bait with defined histones and use it to go fishing in the nucleus – and then it gets exciting to see what we will have on our ‘hook’," says Bartke.

DNA repair in focus

In their current research work, Bartke and his team used this method to search for proteins that bind specifically to newly formed chromatin*. "The idea was to identify proteins that are able to differentiate between old and new chromatin and that therefore have a function in the replication and repair of DNA," says the molecular biologist. The researchers found a group of structurally related enzyme complexes that are involved in the cell's choice of DNA repair pathway.**

In further investigations, Danish colleagues led by Anja Groth at the Biotech Research and Innovation Centre (BRIC) of the University of Copenhagen elucidated in detail which proteins and structural elements participate in the cell's decision which of the different DNA repair mechanisms to initiate.

Approach for cancer treatment?

The key element in this repair process is an enzyme complex associated with BRCA1 (abbreviation for 'Breast Cancer 1'), a gene which has received considerable attention as a risk marker for breast cancer.*** "Carriers of mutations in the BRCA1 gene have an increased risk of developing breast or ovarian cancer because their DNA damage repair system is faulty, and this in consequence can lead to an accumulation of further harmful mutations. However, cancer patients who carry mutations in the BRCA1 gene can be treated with PARP inhibitors, a class of drugs that are particularly effective in these patients," says Bartke.

As part of the publication, British scientists led by Ross Chapman at the Wellcome Centre for Human Genetics in Oxford then specifically investigated the effects of mutations in the BRCA1 complex, focusing on the part responsible for the recognition of the newly formed chromatin. Cells in which this region was inactivated could be killed very effectively by a PARP inhibitor.

"Due to the collaboration of our three research groups, we now know the exact function of these important DNA repair proteins, and with the chromatin binding site of the BRCA1 complex we have already identified a target structure that we can use for medical intervention in order to treat cancer patients. Using small molecules, it would for example be possible to imitate the BRCA1 mutation and thereby make PARP inhibitors usable for a broader spectrum of patients that do not carry this mutation." A promising start has been made, says Bartke, and companies are already developing such molecules.

Further Information

* Whereas in old chromatin the lysine in position 20 of histone H4 (H4K20) is almost always modified with two methyl groups (H4K20me2), the chromatin that is newly formed during DNA synthesis is characterized by (still) no methyl groups being present at this position (H4K20me0). By comparing these two states and the proteins bound to them, Bartke and his team were able to identify protein complexes that specifically recognize newly formed chromatin (H4K20me0) and therefore must have a function in the replication and repair of the genetic material.

** In the 'non-homologous end joining' pathway two non-homologous ends of the DNA are joined together if there is no sister chromatid available that can serve as a template. This method is very error-prone and as a result leads to mutations in the genome. Homologous recombination, on the other hand, repairs DNA damage using the intact genetic information on the sister chromatid and is considered to be virtually error-free.

*** The actress Angelina Jolie, for example, underwent a precautionary breast amputation because she carries an inherited mutation in the BRCA1 gene.

Further Information

As German Research Center for Environmental Health, Helmholtz Zentrum München pursues the goal of developing personalized medical approaches for the prevention and therapy of major common diseases such as diabetes mellitus and lung diseases. To achieve this, it investigates the interaction of genetics, environmental factors and lifestyle. The Helmholtz Zentrum München has about 2,300 staff members and is headquartered in Neuherberg in the north of Munich. Helmholtz Zentrum München is a member of the Helmholtz Association, a community of 18 scientific-technical and medical-biological research centers with a total of about 37,000 staff members. http://www.helmholtz-muenchen.de/en

The Institute of Functional Epigenetics is interested in how genes are packaged within the nucleus of a cell. The focus is on the so-called "histone proteins" on which the DNA strands are wound and that can determine whether a gene can be read or not. In addition, we are examining the connections between common diseases and distortions in DNA packing. We utilize cutting edge methods that enable us to follow changes of these processes even in individual cells. http://www.helmholtz-muenchen.de/ife/index.html

Contact for the media:
Department of Communication, Helmholtz Zentrum München - German Research Center for Environmental Health, Ingolstädter Landstr. 1, 85764 Neuherberg - Tel. +49 89 3187 2238 - E-mail: presse@helmholtz-muenchen.de

Wissenschaftliche Ansprechpartner:

Dr. Till Bartke, Helmholtz Zentrum München - German Research Center for Environmental Health, Institute of Functional Epigenetics, Ingolstädter Landstr. 1, 85764 Neuherberg - Tel. +49 89 3187 1553, E-mail: till.bartke@helmholtz-muenchen.de

Originalpublikation:

Nakamura, K. & Saredi, G. & Becker, J.R. et al. (2019): H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination in sister chromatids. Nature Cell Biology, DOI: 10.1038/s41556-019-0282-9

Sonja Opitz | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
Further information:
https://www.helmholtz-muenchen.de/

Further reports about: BRCA1 BRCA1 gene DNA DNA repair Environmental Health diseases histones mutations proteins repair

More articles from Life Sciences:

nachricht Numbers count in the genetics of moles and melanomas
16.08.2019 | University of Queensland

nachricht Working out why plants get sick
16.08.2019 | Institut für Pflanzenbiochemie

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A miniature stretchable pump for the next generation of soft robots

Soft robots have a distinct advantage over their rigid forebears: they can adapt to complex environments, handle fragile objects and interact safely with humans. Made from silicone, rubber or other stretchable polymers, they are ideal for use in rehabilitation exoskeletons and robotic clothing. Soft bio-inspired robots could one day be deployed to explore remote or dangerous environments.

Most soft robots are actuated by rigid, noisy pumps that push fluids into the machines' moving parts. Because they are connected to these bulky pumps by tubes,...

Im Focus: Vehicle Emissions: New sensor technology to improve air quality in cities

Researchers at TU Graz are working together with European partners on new possibilities of measuring vehicle emissions.

Today, air pollution is one of the biggest challenges facing European cities. As part of the Horizon 2020 research project CARES (City Air Remote Emission...

Im Focus: Self healing robots that "feel pain"

Over the next three years, researchers from the Vrije Universiteit Brussel, University of Cambridge, École Supérieure de Physique et de Chimie Industrielles de la ville de Paris (ESPCI-Paris) and Empa will be working together with the Dutch Polymer manufacturer SupraPolix on the next generation of robots: (soft) robots that ‘feel pain’ and heal themselves. The partners can count on 3 million Euro in support from the European Commission.

Soon robots will not only be found in factories and laboratories, but will be assisting us in our immediate environment. They will help us in the household, to...

Im Focus: Scientists create the world's thinnest gold

Scientists at the University of Leeds have created a new form of gold which is just two atoms thick - the thinnest unsupported gold ever created.

The researchers measured the thickness of the gold to be 0.47 nanometres - that is one million times thinner than a human finger nail. The material is regarded...

Im Focus: Study on attosecond timescale casts new light on electron dynamics in transition metals

An international team of scientists involving the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) in Hamburg has unraveled the light-induced electron-localization dynamics in transition metals at the attosecond timescale. The team investigated for the first time the many-body electron dynamics in transition metals before thermalization sets in. Their work has now appeared in Nature Physics.

The researchers from ETH Zurich (Switzerland), the MPSD (Germany), the Center for Computational Sciences of University of Tsukuba (Japan) and the Center for...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

The power of thought – the key to success: CYBATHLON BCI Series 2019

16.08.2019 | Event News

4th Hybrid Materials and Structures 2020 28 - 29 April 2020, Karlsruhe, Germany

14.08.2019 | Event News

What will the digital city of the future look like? City Science Summit on 1st and 2nd October 2019 in Hamburg

12.08.2019 | Event News

 
Latest News

Working out why plants get sick

16.08.2019 | Life Sciences

Newfound superconductor material could be the 'silicon of quantum computers'

16.08.2019 | Physics and Astronomy

Stanford develops wireless sensors that stick to the skin to track our health

16.08.2019 | Medical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>